Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the RNA-Based Vaccines industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Silence Therapeutics
RXi
Benitec Biopharma
Gradalis
Roche
Abbott Laboratories
Sanofi-Aventis
Senesco
Silenseed
Alnylam Pharmaceuticals
Quark
Arrowhead Pharmaceuticals
Dicerna
Calimmune Inc
Pfizer
Tekmira
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
RNA-based Therapeutics
RNA-Based Vaccines
Application:
Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 RNA-Based Vaccines Industry Overview
-
1.1.1 RNA-Based Vaccines Market Scope and Market Segments
-
1.1.2 RNA-Based Vaccines Industry Characteristics
-
1.1.3 Global and China RNA-Based Vaccines Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China RNA-Based Vaccines Production Value and Growth Rate (2017-2028)
-
1.2 Global RNA-Based Vaccines Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 RNA-based Therapeutics
-
1.2.2 RNA-Based Vaccines
-
1.3 Global RNA-Based Vaccines Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Cancer
-
1.3.2 Diabetes
-
1.3.3 Tuberculosis
-
1.3.4 Cardiovascular Diseases
-
1.3.5 Others
-
1.4 Market Analysis by Region
-
1.4.1 North America RNA-Based Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe RNA-Based Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC RNA-Based Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa RNA-Based Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global RNA-Based Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global RNA-Based Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China RNA-Based Vaccines Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China RNA-Based Vaccines Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global RNA-Based Vaccines Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 RNA-Based Vaccines Industry Porter's Five Forces Model Analysis
-
2.2.3 RNA-Based Vaccines Industry PEST Analysis
-
2.3 RNA-Based Vaccines Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 RNA-Based Vaccines Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on RNA-Based Vaccines Industry
Chapter 3 Global and China RNA-Based Vaccines Market, by Manufacturer
-
3.1 Global and China RNA-Based Vaccines Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China RNA-Based Vaccines Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China RNA-Based Vaccines Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China RNA-Based Vaccines Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China RNA-Based Vaccines Market Top 3 Players
Chapter 4 Global and China RNA-Based Vaccines Market, by Type (2017-2028)
-
4.1 RNA-Based Vaccines Market Trend, by Type
-
4.2 Global RNA-Based Vaccines Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global RNA-Based Vaccines Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global RNA-Based Vaccines Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global RNA-Based Vaccines Price Trend, by Type (2017-2028)
-
4.3 China RNA-Based Vaccines Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China RNA-Based Vaccines Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China RNA-Based Vaccines Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China RNA-Based Vaccines Price Trend, by Type (2017-2028)
Chapter 5 Global and China RNA-Based Vaccines Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global RNA-Based Vaccines Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global RNA-Based Vaccines Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global RNA-Based Vaccines Sales Value and Market Share, by Application (2017-2028)
-
5.3 China RNA-Based Vaccines Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China RNA-Based Vaccines Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China RNA-Based Vaccines Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global RNA-Based Vaccines Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China RNA-Based Vaccines Production, Import, Consumption and Export (2017-2022)
-
6.2 North America RNA-Based Vaccines Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe RNA-Based Vaccines Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC RNA-Based Vaccines Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa RNA-Based Vaccines Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America RNA-Based Vaccines Market Analysis
-
7.1 North America RNA-Based Vaccines Market, by Type
-
7.2 North America RNA-Based Vaccines Market, by Application
-
7.3 North America RNA-Based Vaccines Market Analysis and Forecast, by Country
-
7.3.1 United States RNA-Based Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada RNA-Based Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico RNA-Based Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe RNA-Based Vaccines Market Analysis
-
8.1 Europe RNA-Based Vaccines Market, by Type
-
8.2 Europe RNA-Based Vaccines Market, by Application
-
8.3 Europe RNA-Based Vaccines Market Analysis and Forecast, by Country
-
8.3.1 Germany RNA-Based Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK RNA-Based Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France RNA-Based Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy RNA-Based Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries RNA-Based Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain RNA-Based Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium RNA-Based Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland RNA-Based Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia RNA-Based Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey RNA-Based Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC RNA-Based Vaccines Market Analysis
-
9.1 APAC RNA-Based Vaccines Market, by Type
-
9.2 APAC RNA-Based Vaccines Market, by Application
-
9.3 APAC RNA-Based Vaccines Market Analysis and Forecast, by Country
-
9.3.1 China RNA-Based Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan RNA-Based Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand RNA-Based Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India RNA-Based Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries RNA-Based Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea RNA-Based Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa RNA-Based Vaccines Market Analysis
-
10.1 Latin America, Middle East and Africa RNA-Based Vaccines Market, by Type
-
10.2 Latin America, Middle East and Africa RNA-Based Vaccines Market, by Application
-
10.3 Latin America, Middle East and Africa RNA-Based Vaccines Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries RNA-Based Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil RNA-Based Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria RNA-Based Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa RNA-Based Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina RNA-Based Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China RNA-Based Vaccines Company Profiles
-
11.1 Silence Therapeutics
-
11.1.1 Silence Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Silence Therapeutics RNA-Based Vaccines Product Profiles, Application and Specification
-
11.1.3 Silence Therapeutics RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 RXi
-
11.2.1 RXi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 RXi RNA-Based Vaccines Product Profiles, Application and Specification
-
11.2.3 RXi RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Benitec Biopharma
-
11.3.1 Benitec Biopharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Benitec Biopharma RNA-Based Vaccines Product Profiles, Application and Specification
-
11.3.3 Benitec Biopharma RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Gradalis
-
11.4.1 Gradalis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Gradalis RNA-Based Vaccines Product Profiles, Application and Specification
-
11.4.3 Gradalis RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Roche
-
11.5.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Roche RNA-Based Vaccines Product Profiles, Application and Specification
-
11.5.3 Roche RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Abbott Laboratories
-
11.6.1 Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Abbott Laboratories RNA-Based Vaccines Product Profiles, Application and Specification
-
11.6.3 Abbott Laboratories RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Sanofi-Aventis
-
11.7.1 Sanofi-Aventis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Sanofi-Aventis RNA-Based Vaccines Product Profiles, Application and Specification
-
11.7.3 Sanofi-Aventis RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Senesco
-
11.8.1 Senesco Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Senesco RNA-Based Vaccines Product Profiles, Application and Specification
-
11.8.3 Senesco RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Silenseed
-
11.9.1 Silenseed Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Silenseed RNA-Based Vaccines Product Profiles, Application and Specification
-
11.9.3 Silenseed RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Alnylam Pharmaceuticals
-
11.10.1 Alnylam Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Alnylam Pharmaceuticals RNA-Based Vaccines Product Profiles, Application and Specification
-
11.10.3 Alnylam Pharmaceuticals RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 Quark
-
11.11.1 Quark Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 Quark RNA-Based Vaccines Product Profiles, Application and Specification
-
11.11.3 Quark RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 Arrowhead Pharmaceuticals
-
11.12.1 Arrowhead Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 Arrowhead Pharmaceuticals RNA-Based Vaccines Product Profiles, Application and Specification
-
11.12.3 Arrowhead Pharmaceuticals RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 Dicerna
-
11.13.1 Dicerna Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 Dicerna RNA-Based Vaccines Product Profiles, Application and Specification
-
11.13.3 Dicerna RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.14 Calimmune Inc
-
11.14.1 Calimmune Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.14.2 Calimmune Inc RNA-Based Vaccines Product Profiles, Application and Specification
-
11.14.3 Calimmune Inc RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.15 Pfizer
-
11.15.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.15.2 Pfizer RNA-Based Vaccines Product Profiles, Application and Specification
-
11.15.3 Pfizer RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.16 Tekmira
-
11.16.1 Tekmira Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.16.2 Tekmira RNA-Based Vaccines Product Profiles, Application and Specification
-
11.16.3 Tekmira RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 RNA-Based Vaccines Industry Investment Prospect and Risk Assessment
-
12.1 RNA-Based Vaccines Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 RNA-Based Vaccines Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global RNA-Based Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure China RNA-Based Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Global RNA-Based Vaccines Production Value and Growth Rate (2017-2028)
-
Figure China RNA-Based Vaccines Production Value and Growth Rate (2017-2028)
-
Figure Global RNA-Based Vaccines Market Size and Growth Rate of RNA-based Therapeutics (2017-2028)
-
Figure Global RNA-Based Vaccines Market Size and Growth Rate of RNA-Based Vaccines (2017-2028)
-
Figure Global RNA-Based Vaccines Market Size and Growth Rate of Cancer (2017-2028)
-
Figure Global RNA-Based Vaccines Market Size and Growth Rate of Diabetes (2017-2028)
-
Figure Global RNA-Based Vaccines Market Size and Growth Rate of Tuberculosis (2017-2028)
-
Figure Global RNA-Based Vaccines Market Size and Growth Rate of Cardiovascular Diseases (2017-2028)
-
Figure Global RNA-Based Vaccines Market Size and Growth Rate of Others (2017-2028)
-
Figure North America RNA-Based Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe RNA-Based Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC RNA-Based Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa RNA-Based Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global RNA-Based Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China RNA-Based Vaccines Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China RNA-Based Vaccines Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China RNA-Based Vaccines Sales Value, by Manufacturer (2021&2022)
-
Table Global and China RNA-Based Vaccines Market Share, by Manufacturer (2021&2022)
-
Figure Global and China RNA-Based Vaccines Market Share, by Manufacturer in 2021
-
Figure Global and China RNA-Based Vaccines Market Share, by Manufacturer in 2022
-
Table Global RNA-Based Vaccines Sales Volume, by Type (2017-2028)
-
Table Global RNA-Based Vaccines Sales Volume Share, by Type (2017-2028)
-
Figure Global RNA-Based Vaccines Sales Volume Share, by Type (2017-2028)
-
Table Global RNA-Based Vaccines Sales Value, by Type (2017-2028)
-
Table Global RNA-Based Vaccines Sales Value Share, by Type (2017-2028)
-
Figure Global RNA-Based Vaccines Price Trend, by Type (2017-2028)
-
Table China RNA-Based Vaccines Sales Volume, by Type (2017-2028)
-
Table China RNA-Based Vaccines Sales Volume Share, by Type (2017-2028)
-
Figure China RNA-Based Vaccines Sales Volume Share, by Type (2017-2028)
-
Table China RNA-Based Vaccines Sales Value, by Type (2017-2028)
-
Table China RNA-Based Vaccines Sales Value Share, by Type (2017-2028)
-
Figure China RNA-Based Vaccines Price Trend, by Type (2017-2028)
-
Table Global RNA-Based Vaccines Sales Volume, by Application (2017-2028)
-
Table Global RNA-Based Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure Global RNA-Based Vaccines Sales Volume Share, by Application (2017-2028)
-
Table Global RNA-Based Vaccines Sales Value, by Application (2017-2028)
-
Table Global RNA-Based Vaccines Sales Value Share, by Application (2017-2028)
-
Figure Global RNA-Based Vaccines Sales Value Share, by Application (2017-2028)
-
Table China RNA-Based Vaccines Sales Volume, by Application (2017-2028)
-
Table China RNA-Based Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure China RNA-Based Vaccines Sales Volume Share, by Application (2017-2028)
-
Table China RNA-Based Vaccines Sales Value, by Application (2017-2028)
-
Table China RNA-Based Vaccines Sales Value Share, by Application (2017-2028)
-
Figure China RNA-Based Vaccines Sales Value Share, by Application (2017-2028)
-
Figure China RNA-Based Vaccines Production, Import, Consumption and Export (2017-2022)
-
Figure North America RNA-Based Vaccines Production, Import, Consumption and Export (2017-2022)
-
Figure Europe RNA-Based Vaccines Production, Import, Consumption and Export (2017-2022)
-
Figure APAC RNA-Based Vaccines Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa RNA-Based Vaccines Production, Import, Consumption and Export (2017-2022)
-
Table North America RNA-Based Vaccines Sales Volume, by Type (2017-2028)
-
Table North America RNA-Based Vaccines Sales Volume Share, by Type (2017-2028)
-
Figure North America RNA-Based Vaccines Sales Volume Share, by Type (2017-2028)
-
Table North America RNA-Based Vaccines Sales Volume, by Application (2017-2028)
-
Table North America RNA-Based Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure North America RNA-Based Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure United States RNA-Based Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure United States RNA-Based Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Canada RNA-Based Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Canada RNA-Based Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Mexico RNA-Based Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico RNA-Based Vaccines Sales Value and Growth Rate (2017-2028)
-
Table Europe RNA-Based Vaccines Sales Volume, by Type (2017-2028)
-
Table Europe RNA-Based Vaccines Sales Volume Share, by Type (2017-2028)
-
Figure Europe RNA-Based Vaccines Sales Volume Share, by Type (2017-2028)
-
Table Europe RNA-Based Vaccines Sales Volume, by Application (2017-2028)
-
Table Europe RNA-Based Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure Europe RNA-Based Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure Germany RNA-Based Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Germany RNA-Based Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure UK RNA-Based Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure UK RNA-Based Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure France RNA-Based Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure France RNA-Based Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Italy RNA-Based Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Italy RNA-Based Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries RNA-Based Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries RNA-Based Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Spain RNA-Based Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Spain RNA-Based Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Belgium RNA-Based Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium RNA-Based Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Poland RNA-Based Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Poland RNA-Based Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Russia RNA-Based Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Russia RNA-Based Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Turkey RNA-Based Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey RNA-Based Vaccines Sales Value and Growth Rate (2017-2028)
-
Table APAC RNA-Based Vaccines Sales Volume, by Type (2017-2028)
-
Table APAC RNA-Based Vaccines Sales Volume Share, by Type (2017-2028)
-
Figure APAC RNA-Based Vaccines Sales Volume Share, by Type (2017-2028)
-
Table APAC RNA-Based Vaccines Sales Volume, by Application (2017-2028)
-
Table APAC RNA-Based Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure APAC RNA-Based Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure China RNA-Based Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure China RNA-Based Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Japan RNA-Based Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Japan RNA-Based Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand RNA-Based Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand RNA-Based Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure India RNA-Based Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure India RNA-Based Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries RNA-Based Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries RNA-Based Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure South Korea RNA-Based Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea RNA-Based Vaccines Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa RNA-Based Vaccines Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa RNA-Based Vaccines Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa RNA-Based Vaccines Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa RNA-Based Vaccines Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa RNA-Based Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa RNA-Based Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries RNA-Based Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries RNA-Based Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Brazil RNA-Based Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil RNA-Based Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria RNA-Based Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria RNA-Based Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure South Africa RNA-Based Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa RNA-Based Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Argentina RNA-Based Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina RNA-Based Vaccines Sales Value and Growth Rate (2017-2028)
-
Table Silence Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Silence Therapeutics Product Profiles, Application and Specification
-
Table Silence Therapeutics RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table RXi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table RXi Product Profiles, Application and Specification
-
Table RXi RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Benitec Biopharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Benitec Biopharma Product Profiles, Application and Specification
-
Table Benitec Biopharma RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Gradalis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Gradalis Product Profiles, Application and Specification
-
Table Gradalis RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Roche Product Profiles, Application and Specification
-
Table Roche RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Abbott Laboratories Product Profiles, Application and Specification
-
Table Abbott Laboratories RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sanofi-Aventis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sanofi-Aventis Product Profiles, Application and Specification
-
Table Sanofi-Aventis RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Senesco Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Senesco Product Profiles, Application and Specification
-
Table Senesco RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Silenseed Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Silenseed Product Profiles, Application and Specification
-
Table Silenseed RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Alnylam Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Alnylam Pharmaceuticals Product Profiles, Application and Specification
-
Table Alnylam Pharmaceuticals RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Quark Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Quark Product Profiles, Application and Specification
-
Table Quark RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Arrowhead Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Arrowhead Pharmaceuticals Product Profiles, Application and Specification
-
Table Arrowhead Pharmaceuticals RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Dicerna Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Dicerna Product Profiles, Application and Specification
-
Table Dicerna RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Calimmune Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Calimmune Inc Product Profiles, Application and Specification
-
Table Calimmune Inc RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Pfizer Product Profiles, Application and Specification
-
Table Pfizer RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Tekmira Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Tekmira Product Profiles, Application and Specification
-
Table Tekmira RNA-Based Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
